美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

猴痘概念

1,701.43

-4.6825-0.27%

涨家数：3

跌家数：7

平家数：1

市盈率：- -

高：1,710.37

开：1,703.83

低：1,673.97

收：1,706.11

成交量：1,919.42万

成交额：10.99亿

市值：1,895.57亿

流通市值：1,890.34亿

数据加载中...

总览新闻资讯

e家快服盘中异动股价大跌6.56%报0.953美元

吉利德科学的单片剂方案在III期ARTISTRY-1试验中达到主要终点

新闻稿：Emergent BioSolutions公告路易斯·W·沙利文博士退休董事会成员

伊诺维奥制药：若优先审查请求获批，Ino-3107的潜在PDUFA日期在2026年中期

吉利德科学首席财务官表示公司将继续积极开展业务发展，包括许可和并购

吉利德科学首席财务官表示医保改革对艾滋病业务影响约为9亿美元，整体业务影响达12亿美元

生命科学领域引来“东升西落”：美国医药业低迷，中国崛起

财经实验室TheF...

吉利德：Trop2 ADC一线治疗HR+/HER2-乳腺三期临床失败

吉利德：预计2024年第四季度可享受4.5亿美元的所得税优惠，同时减少对应的5.3亿美元未确认税收优惠

吉利德科学：10月与税务机关达成与前一年法律实体重组相关的和解 - 文件

吉利德科学股价下跌2.2%，乳腺癌药物未达晚期研究主要目标

吉利德乳腺癌药物未能达到后期研究的主要目标

吉利德：安全性特征与之前Trodelvy乳腺癌研究一致，未在该患者群体中发现新的安全性信号

吉利德：Livdelzi独家新数据凸显其作为PBC患者有效且耐受良好选择的潜力

吉利德的Livdelzi®在原发性胆汁性胆管炎（PBC）中显示持续疗效，提供碱性磷酸酶（Alp）降低、缓解瘙痒及减缓疾病进展的潜力

吉利德科学携两款亚洲首发展品亮相进博会

Aethlon Medical, Inc.盘中异动股价大跌5.10%报4.28美元

Viatris高管表示印多尔工厂初步修复工作基本完成，并与FDA就进展和重新检查的潜在时间进行了讨论 - 会议电话

品牌药需求强劲，伟哥生产商 Viatris 季度业绩超出预期

由于 COVID 疫苗销售疲软，莫德纳下调了全年预期上限

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK4583/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4583\",,,,,undefined,":{"symbol":"BK4583","market":"US","secType":"PLATE","nameCN":"猴痘概念","latestPrice":1701.4254,"timestamp":1763153999999,"preClose":1706.1079,"halted":0,"volume":19194191,"delay":0,"changeRate":-0.002745,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":-4.682495,"latestTime":"11-14 16:00:00 EST","open":1703.8335,"high":1710.3693,"low":1673.969,"amount":1099426121.723852,"amplitude":0.021335,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1763389800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.22069,"peRate":35.951527,"turnoverRate":0.00711,"increases":3,"decrements":7,"flats":0,"marketCap":189557488732.5,"floatMarketCap":189033848271.875},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4583\",,,,,undefined,":{"symbol":"BK4583","high":1710.3693,"amplitude":0.021335,"preClose":1706.1079,"low":1673.969,"pbRate":"4.22069","latestPrice":1701.4254,"volume":19194191,"delay":0,"open":1703.8335,"prevYearClose":1284.7982,"prevWeekClose":1701.4254,"prevMonthClose":1630.7106,"prevQuarterClose":1540.8464,"fiveDayClose":1619.0988,"twentyDayClose":1674.3417,"sixtyDayClose":1591.1555,"secType":"PLATE","market":"US","turnoverRate":0.00711,"peRate":35.951527,"marketCap":189557488732.5,"floatMarketCap":189033848271.875,"timestamp":1763153999999,"nameCN":"猴痘概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4583\",,,,undefined,":{"bkCode":"BK4583","up":3,"down":7,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4583\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2583557639","title":"e家快服盘中异动 股价大跌6.56%报0.953美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583557639","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583557639?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 01:21","pubTimestamp":1763054467,"startTime":"0","endTime":"0","summary":"北京时间2025年11月14日01时21分，e家快服股票出现异动，股价大幅下跌6.56%。截至发稿，该股报0.953美元/股，成交量4.4146万股，换手率0.22%，振幅4.90%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。e家快服股票所在的消费者服务行业中，整体跌幅为0.43%。该公司提供的服务包括家电安装和家政服务。其业务分为四个报告分部：家电安装及维修服务、家政服务、养老服务和教育咨询服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114012107a49f896c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114012107a49f896c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","EJH","BK4192","BK4583"],"gpt_icon":0},{"id":"1188771558","title":"吉利德科学的单片剂方案在III期ARTISTRY-1试验中达到主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=1188771558","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188771558?lang=zh_cn&edition=fundamental","pubTime":"2025-11-13 21:31","pubTimestamp":1763040716,"startTime":"0","endTime":"0","summary":"吉利德科学的单片剂方案Bictegravir和Lenacapavir用于HIV-1治疗在III期ARTISTRY-1试验中达到了主要终点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","IE00B19Z3581.USD","LU1585245621.USD","BK4583","LU1839511570.USD","BK4588","LU1571399168.USD","BK4585","IE00BZ1G4Q59.USD","SG9999015986.USD","GILD","LU1674673691.USD","BK4568","IE00B19Z3B42.SGD","LU0289739699.SGD","IE00BKVL7J92.USD","LU0889565916.HKD","LU1674673428.USD","BK4139","LU0882574055.USD","LU0109394709.USD","LU2468319806.SGD","LU1066051498.USD","BK4550","IE00B7SZLL34.SGD","LU0320765992.SGD","LU2087621335.USD","BK4532","LU0823416689.USD","LU1430594728.SGD","IE00BSNM7G36.USD","SG9999015978.USD","IE0002270589.USD","BK4566","LU0234570918.USD","LU1778281490.HKD","IE00B3T34201.USD","LU2089984988.USD","LU1066053197.SGD","BK4578","LU0114720955.EUR","LU2324357040.USD","SG9999015952.SGD","SG9999015945.SGD"],"gpt_icon":0},{"id":"1187056351","title":"新闻稿：Emergent BioSolutions公告路易斯·W·沙利文博士退休董事会成员","url":"https://stock-news.laohu8.com/highlight/detail?id=1187056351","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187056351?lang=zh_cn&edition=fundamental","pubTime":"2025-11-13 05:04","pubTimestamp":1762981475,"startTime":"0","endTime":"0","summary":"马里兰州盖瑟斯堡，2025年11月12日—— Emergent BioSolutions今天宣布，路易斯·W·沙利文博士将在公司董事会任期内于11月14日退休，结束他为公司及其股东服务的19年历程。“我代表董事会以及整个Emergent团队，感谢他卓越的领导和贡献。我们祝愿他一切顺利。”沙利文博士自2006年起担任Emergent董事会成员，最近担任薪酬委员会主席，并参与提名和公司治理委员会。在Emergent，我们的使命是保护和拯救生命。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","BK4139","EBS"],"gpt_icon":0},{"id":"1102265080","title":"伊诺维奥制药：若优先审查请求获批，Ino-3107的潜在PDUFA日期在2026年中期","url":"https://stock-news.laohu8.com/highlight/detail?id=1102265080","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102265080?lang=zh_cn&edition=fundamental","pubTime":"2025-11-11 05:53","pubTimestamp":1762811589,"startTime":"0","endTime":"0","summary":"伊诺维奥制药：若优先审查请求获批，Ino-3107的潜在PDUFA日期在2026年中期","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4583","INO","BK4568"],"gpt_icon":0},{"id":"1157913444","title":"吉利德科学首席财务官表示公司将继续积极开展业务发展，包括许可和并购","url":"https://stock-news.laohu8.com/highlight/detail?id=1157913444","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157913444?lang=zh_cn&edition=fundamental","pubTime":"2025-11-11 00:35","pubTimestamp":1762792519,"startTime":"0","endTime":"0","summary":"吉利德科学首席财务官表示公司将继续积极开展业务发展，包括许可和并购。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","LU1674673428.USD","BK4550","BK4578","IE00B19Z3B42.SGD","LU0320765992.SGD","LU2468319806.SGD","LU1778281490.HKD","LU0109394709.USD","BK4532","LU1066053197.SGD","SG9999015986.USD","BK4568","IE00BZ1G4Q59.USD","LU1674673691.USD","LU1571399168.USD","IE00BKVL7J92.USD","LU0114720955.EUR","LU0882574055.USD","LU1430594728.SGD","SG9999015945.SGD","LU0234570918.USD","BK4583","BK4588","GILD","LU0823416689.USD","LU0889565916.HKD","LU2087621335.USD","SG9999015952.SGD","IE00B3T34201.USD","IE0002270589.USD","BK4139","IE00B7SZLL34.SGD","LU2089984988.USD","BK4566","SG9999015978.USD","BK4585","LU1585245621.USD","LU2324357040.USD","LU1066051498.USD","IE00BSNM7G36.USD","LU1839511570.USD","LU0289739699.SGD","LU0058720904.USD"],"gpt_icon":0},{"id":"1145102354","title":"吉利德科学首席财务官表示医保改革对艾滋病业务影响约为9亿美元，整体业务影响达12亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1145102354","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145102354?lang=zh_cn&edition=fundamental","pubTime":"2025-11-11 00:13","pubTimestamp":1762791201,"startTime":"0","endTime":"0","summary":"吉利德科学首席财务官表示，医保改革对艾滋病业务的影响约为9亿美元，整体业务的影响则达到12亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00B7SZLL34.SGD","IE0002270589.USD","LU2087621335.USD","LU2089984988.USD","BK4532","LU1674673428.USD","LU1674673691.USD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","BK4585","LU0889565916.HKD","LU1430594728.SGD","IE00BZ1G4Q59.USD","LU1066051498.USD","SG9999015952.SGD","LU0114720955.EUR","LU1778281490.HKD","IE00BKVL7J92.USD","IE00B3T34201.USD","LU2468319806.SGD","LU1066053197.SGD","SG9999015945.SGD","LU1585245621.USD","LU0109394709.USD","LU2324357040.USD","BK4578","LU0882574055.USD","BK4566","SG9999015986.USD","LU0058720904.USD","BK4583","BK4568","LU0320765992.SGD","IE00B19Z3581.USD","BK4139","BK4550","LU0234570918.USD","LU0289739699.SGD","LU0823416689.USD","LU1571399168.USD","GILD","LU1839511570.USD","SG9999015978.USD"],"gpt_icon":0},{"id":"2582862497","title":"生命科学领域引来“东升西落”：美国医药业低迷，中国崛起","url":"https://stock-news.laohu8.com/highlight/detail?id=2582862497","media":"财经实验室TheF...","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582862497?lang=zh_cn&edition=fundamental","pubTime":"2025-11-08 10:26","pubTimestamp":1762568768,"startTime":"0","endTime":"0","summary":"Pfizer、Gilead Sciences、GE HealthCare及Illumina均报告销售或利润下滑，S&P 500医疗类股一年内微跌1%，而指数整体上涨19%。相较之下，中国生命科学产业迅速反弹。约550家市值超过2亿美元的中国医疗企业总市值接近1.2万亿美元，较年初增长46%，远超美国同行。2025年上半年，中国开发者占全球药物授权交易总额的32%，较2011至2021年平均不足3%显著提升。中国已成为创新药物研发的重要来源，利用国家资助、科研成果转化、风险投资与大型药企协同模式推动行业增长。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251108103310a491b1d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251108103310a491b1d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0306806265.USD","LU1674673691.USD","LU0058720904.USD","SG9999015952.SGD","LU1585245621.USD","BK4566","LU0114720955.EUR","LU1894683348.USD","GILD","BK4583","LU0234570918.USD","IE00B19Z3B42.SGD","LU1057294990.SGD","LU0321505439.SGD","LU0889565916.HKD","LU0225284248.USD","BK4533","IE00BBT3K403.USD","SG9999015978.USD","LU0109394709.USD","IE0002270589.USD","LU2324357040.USD","SG9999003800.SGD","LU1066051498.USD","LU1883839398.USD","LU1571399168.USD","LU1066053197.SGD","BK4599","IE00B19Z3581.USD","SG9999002232.USD","LU0985481810.HKD","LU1430594728.SGD","LU0823416689.USD","LU1778281490.HKD","BK4592","LU0122379950.USD","LU1894683264.USD","LU2468319806.SGD","LU0882574055.USD","SG9999001176.SGD","LU0456855351.SGD","LU0234572021.USD","LU1839511570.USD","PFE","BK4581","BK4007","IE00B7SZLL34.SGD","LU0321505868.SGD","LU0289739699.SGD","SG9999013999.USD"],"gpt_icon":0},{"id":"2582862418","title":"吉利德：Trop2 ADC一线治疗HR+/HER2-乳腺三期临床失败","url":"https://stock-news.laohu8.com/highlight/detail?id=2582862418","media":"医药笔记","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582862418?lang=zh_cn&edition=fundamental","pubTime":"2025-11-08 09:31","pubTimestamp":1762565499,"startTime":"0","endTime":"0","summary":"▎Armstrong2025年11月7日，吉利德宣布Trop2 ADC新药Trodelvy对比化疗一线治疗内分泌治疗后HR+/HER2-乳腺癌的三期临床ASCENT-07没有达到PFS主要终点，关键次要终点OS尚未成熟，但观察到获益趋势，研究将继续进行以评估OS数据。Trodelvy一线治疗三阴乳腺癌已经递交上市申请。总结吉利德Trodelvy为全球首款Trop2 ADC，但作为上一代ADC在适应症拓展的道路上充满曲折，先后在非小细胞肺癌、尿路上皮癌失败，此次HR+/HER2-乳腺癌又错失PFS终点，仅守住三阴乳腺癌这一阵地。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251108093356a6e9fd53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251108093356a6e9fd53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","BK4550","BK4585","BK4231","IE00BSNM7G36.USD","LU1066053197.SGD","ADC","LU0289739699.SGD","LU0058720904.USD","LU0823416689.USD","GILD","IE00B19Z3581.USD","BK4080","LU1066051498.USD","LU2324357040.USD","BK4583","LU0234570918.USD","LU0114720955.EUR","IE00B19Z3B42.SGD","SG9999015986.USD","SG9999015945.SGD","SG9999015978.USD","LU0320765992.SGD","BK4578","LU1585245621.USD","BK4588","HR","LU2087621335.USD","LU0109394709.USD","BK4139","IE00B7SZLL34.SGD","LU1839511570.USD","BK4225","IE00BKVL7J92.USD","BK4532","BK4203","LU1674673691.USD","LU2089984988.USD","BK4566","BK4568","LU1778281490.HKD","LU1430594728.SGD","LU0882574055.USD","LU2468319806.SGD","IE0002270589.USD","IE00B3T34201.USD","SG9999015952.SGD","LU1571399168.USD","IE00BZ1G4Q59.USD","LU1674673428.USD"],"gpt_icon":0},{"id":"1152764069","title":"吉利德：预计2024年第四季度可享受4.5亿美元的所得税优惠，同时减少对应的5.3亿美元未确认税收优惠","url":"https://stock-news.laohu8.com/highlight/detail?id=1152764069","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152764069?lang=zh_cn&edition=fundamental","pubTime":"2025-11-08 05:13","pubTimestamp":1762549994,"startTime":"0","endTime":"0","summary":"吉利德：预计2024年第四季度可享受4.5亿美元的所得税优惠，同时减少对应的5.3亿美元未确认税收优惠。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","LU2468319806.SGD","LU0889565916.HKD","LU1674673691.USD","BK4568","BK4578","BK4588","LU1066051498.USD","IE00B3T34201.USD","SG9999015986.USD","LU2087621335.USD","BK4566","GILD","LU1839511570.USD","LU1066053197.SGD","LU1430594728.SGD","LU0320765992.SGD","BK4139","BK4532","LU1674673428.USD","LU0882574055.USD","IE00B7SZLL34.SGD","BK4585","LU2324357040.USD","SG9999015978.USD","SG9999015945.SGD","LU0823416689.USD","IE0002270589.USD","SG9999015952.SGD","BK4550","LU0289739699.SGD","LU1571399168.USD","LU0058720904.USD","LU1778281490.HKD","IE00BZ1G4Q59.USD","LU0109394709.USD","LU0234570918.USD","BK4583","LU2089984988.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","LU0114720955.EUR","LU1585245621.USD"],"gpt_icon":0},{"id":"1184501887","title":"吉利德科学：10月与税务机关达成与前一年法律实体重组相关的和解 - 文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1184501887","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184501887?lang=zh_cn&edition=fundamental","pubTime":"2025-11-08 05:13","pubTimestamp":1762549993,"startTime":"0","endTime":"0","summary":"吉利德科学：10月与税务机关达成与前一年法律实体重组相关的和解 - 文件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1839511570.USD","SG9999015978.USD","BK4585","IE00B19Z3B42.SGD","LU0234570918.USD","LU0289739699.SGD","BK4550","SG9999015986.USD","LU1430594728.SGD","LU2087621335.USD","IE00BZ1G4Q59.USD","BK4532","LU0882574055.USD","LU2324357040.USD","LU1674673691.USD","LU1778281490.HKD","LU0889565916.HKD","IE00B19Z3581.USD","IE00B7SZLL34.SGD","LU0109394709.USD","LU1066051498.USD","IE00BSNM7G36.USD","BK4583","SG9999015945.SGD","BK4578","LU1571399168.USD","LU2089984988.USD","LU1674673428.USD","BK4568","LU0114720955.EUR","LU0058720904.USD","LU0320765992.SGD","SG9999015952.SGD","GILD","IE00BKVL7J92.USD","LU1585245621.USD","LU2468319806.SGD","BK4139","LU1066053197.SGD","IE00B3T34201.USD","BK4566","IE0002270589.USD","LU0823416689.USD","BK4588"],"gpt_icon":0},{"id":"1157980952","title":"吉利德科学股价下跌2.2%，乳腺癌药物未达晚期研究主要目标","url":"https://stock-news.laohu8.com/highlight/detail?id=1157980952","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157980952?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 22:59","pubTimestamp":1762527560,"startTime":"0","endTime":"0","summary":"吉利德科学股价下跌2.2%，乳腺癌药物未达晚期研究主要目标","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","LU1571399168.USD","LU1778281490.HKD","IE00B3T34201.USD","BK4532","BK4578","LU2087621335.USD","SG9999015978.USD","LU1674673691.USD","IE00B19Z3B42.SGD","LU2089984988.USD","IE00B19Z3581.USD","SG9999015952.SGD","GILD","LU0234570918.USD","LU0320765992.SGD","LU1839511570.USD","SG9999015986.USD","LU0882574055.USD","LU1585245621.USD","LU1066051498.USD","IE00BKVL7J92.USD","IE00BSNM7G36.USD","BK4568","IE00BZ1G4Q59.USD","BK4583","LU0889565916.HKD","BK4585","SG9999015945.SGD","LU1066053197.SGD","LU0058720904.USD","IE00B7SZLL34.SGD","LU0114720955.EUR","LU2324357040.USD","BK4588","LU1430594728.SGD","IE0002270589.USD","BK4139","LU0289739699.SGD","BK4550","LU0109394709.USD","LU0823416689.USD","LU1674673428.USD","BK4566"],"gpt_icon":0},{"id":"2581885593","title":"吉利德乳腺癌药物未能达到后期研究的主要目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2581885593","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581885593?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 21:37","pubTimestamp":1762522627,"startTime":"0","endTime":"0","summary":"吉利德乳腺癌药物未能达到后期研究的主要目标路透11月7日 - 吉利德科学公司GILD.O周五称，其乳腺癌药物Trodelvy未能达到一项晚期研究的主要目标。 (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nL4T3WJ164:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU1585245621.USD","LU2324357040.USD","LU1571399168.USD","BK4578","SG9999015952.SGD","BK4583","IE00B7SZLL34.SGD","IE00BKVL7J92.USD","SG9999015986.USD","LU1674673428.USD","BK4588","LU0058720904.USD","LU1778281490.HKD","LU0234570918.USD","LU1839511570.USD","LU0289739699.SGD","LU0882574055.USD","SG9999015945.SGD","BK4585","LU2089984988.USD","LU1066051498.USD","IE00B3T34201.USD","LU0109394709.USD","BK4550","LU1066053197.SGD","LU2468319806.SGD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","SG9999015978.USD","LU2087621335.USD","LU0320765992.SGD","LU0823416689.USD","BK4566","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","BK4568","LU1430594728.SGD","BK4139","LU1674673691.USD","LU0114720955.EUR","IE0002270589.USD","BK4532","GILD"],"gpt_icon":0},{"id":"1160960792","title":"吉利德：安全性特征与之前Trodelvy乳腺癌研究一致，未在该患者群体中发现新的安全性信号","url":"https://stock-news.laohu8.com/highlight/detail?id=1160960792","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160960792?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 21:31","pubTimestamp":1762522292,"startTime":"0","endTime":"0","summary":"吉利德：安全性特征与之前Trodelvy乳腺癌研究一致，未在该患者群体中发现新的安全性信号","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0882574055.USD","LU0114720955.EUR","LU1066053197.SGD","LU2089984988.USD","SG9999015978.USD","LU0234570918.USD","LU0320765992.SGD","LU1585245621.USD","SG9999015945.SGD","BK4568","LU0289739699.SGD","LU2087621335.USD","LU0109394709.USD","BK4583","IE0002270589.USD","IE00BKVL7J92.USD","LU2324357040.USD","LU1674673691.USD","BK4550","LU1571399168.USD","BK4566","LU1066051498.USD","IE00BZ1G4Q59.USD","LU0058720904.USD","LU1430594728.SGD","LU2468319806.SGD","LU1839511570.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","IE00B7SZLL34.SGD","BK4532","LU0823416689.USD","BK4139","BK4578","LU1778281490.HKD","LU1674673428.USD","BK4585","SG9999015986.USD","GILD","LU0889565916.HKD","SG9999015952.SGD","IE00B3T34201.USD"],"gpt_icon":0},{"id":"1115807732","title":"吉利德：Livdelzi独家新数据凸显其作为PBC患者有效且耐受良好选择的潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=1115807732","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115807732?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 21:02","pubTimestamp":1762520536,"startTime":"0","endTime":"0","summary":"吉利德：Livdelzi独家新数据凸显其作为PBC患者有效且耐受良好选择的潜力","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4583","IE00BZ1G4Q59.USD","LU0889565916.HKD","LU0882574055.USD","LU1839511570.USD","LU2468319806.SGD","SG9999015952.SGD","LU0823416689.USD","BK4588","LU2087621335.USD","BK4578","SG9999015945.SGD","BK4568","LU2089984988.USD","IE00B19Z3581.USD","IE00B3T34201.USD","BK4532","LU0109394709.USD","LU1778281490.HKD","LU1674673691.USD","LU1066051498.USD","LU0234570918.USD","LU1066053197.SGD","GILD","BK4566","IE00BSNM7G36.USD","LU0320765992.SGD","LU1571399168.USD","BK4585","IE00BKVL7J92.USD","SG9999015986.USD","LU1430594728.SGD","IE0002270589.USD","LU0114720955.EUR","LU1674673428.USD","BK4550","LU0289739699.SGD","LU1585245621.USD","IE00B7SZLL34.SGD","IE00B19Z3B42.SGD","LU2324357040.USD","LU0058720904.USD","SG9999015978.USD"],"gpt_icon":0},{"id":"1188865722","title":"吉利德的Livdelzi®在原发性胆汁性胆管炎（PBC）中显示持续疗效，提供碱性磷酸酶（Alp）降低、缓解瘙痒及减缓疾病进展的潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=1188865722","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188865722?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 21:01","pubTimestamp":1762520508,"startTime":"0","endTime":"0","summary":"吉利德的Livdelzi®在原发性胆汁性胆管炎（PBC）中显示出持续的疗效，能够降低碱性磷酸酶（Alp）水平，缓解瘙痒感，并有潜力减缓疾病的进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","LU0320765992.SGD","IE00BSNM7G36.USD","LU1066051498.USD","SG9999015986.USD","BK4532","BK4588","LU1674673691.USD","BK4139","LU0058720904.USD","IE00BKVL7J92.USD","LU2468319806.SGD","IE00B3T34201.USD","BK4550","LU1571399168.USD","BK4585","LU2087621335.USD","LU0109394709.USD","LU1839511570.USD","LU1674673428.USD","GILD","SG9999015952.SGD","LU1778281490.HKD","BK4583","LU0289739699.SGD","SG9999015945.SGD","IE0002270589.USD","IE00B19Z3581.USD","LU0234570918.USD","LU2324357040.USD","BK4578","BK4568","IE00B19Z3B42.SGD","LU0889565916.HKD","SG9999015978.USD","LU1585245621.USD","LU0882574055.USD","LU2089984988.USD","LU0823416689.USD","LU1066053197.SGD","IE00B7SZLL34.SGD","IE00BZ1G4Q59.USD","LU1430594728.SGD","LU0114720955.EUR"],"gpt_icon":0},{"id":"2581079810","title":"吉利德科学携两款亚洲首发展品亮相进博会","url":"https://stock-news.laohu8.com/highlight/detail?id=2581079810","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581079810?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 19:59","pubTimestamp":1762516799,"startTime":"0","endTime":"0","summary":"在第八届中国国际进口博览会（以下简称进博会）上，吉利德科学携多款产品亮相，其中包括两款亚洲首发产品：长效HIV暴露前预防药物Lenacapavir（来那帕韦）和原发性胆汁性胆管炎（PBC）新药Seladelpar，以及在华上市的13款创新药物等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511073558461893.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511073558461893.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1674673691.USD","LU1839511570.USD","BK4588","LU1571399168.USD","IE00B19Z3B42.SGD","SG9999015986.USD","BK4568","SG9999015945.SGD","LU0109394709.USD","LU0234570918.USD","LU0114720955.EUR","IE00B7SZLL34.SGD","BK4139","IE00BSNM7G36.USD","BK4566","BK4578","IE00B3T34201.USD","LU0320765992.SGD","LU1066051498.USD","BK4550","LU1585245621.USD","LU2468319806.SGD","IE00BZ1G4Q59.USD","SG9999015978.USD","IE00B19Z3581.USD","LU1066053197.SGD","BK4585","LU0889565916.HKD","LU2324357040.USD","LU2089984988.USD","BK4532","LU1674673428.USD","BK4583","LU1778281490.HKD","GILD","IE0002270589.USD","IE00BKVL7J92.USD","LU0289739699.SGD","LU0882574055.USD","SG9999015952.SGD","LU2087621335.USD","LU0058720904.USD","LU1430594728.SGD","LU0823416689.USD"],"gpt_icon":0},{"id":"2581020330","title":"Aethlon Medical, Inc.盘中异动 股价大跌5.10%报4.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581020330","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581020330?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 23:11","pubTimestamp":1762441911,"startTime":"0","endTime":"0","summary":"北京时间2025年11月06日23时11分，Aethlon Medical, Inc.股票出现异动，股价急速下跌5.10%。截至发稿，该股报4.28美元/股，成交量1.1533万股，换手率1.52%，振幅2.66%。Aethlon Medical, Inc.股票所在的医疗器械行业中，整体跌幅为0.27%。Aethlon Medical, Inc.公司简介：Aethlon Medical Inc 是一家医疗技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110623115297587038&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110623115297587038&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","AEMD","BK4583","BK4082"],"gpt_icon":0},{"id":"1119940118","title":"Viatris高管表示印多尔工厂初步修复工作基本完成，并与FDA就进展和重新检查的潜在时间进行了讨论 - 会议电话","url":"https://stock-news.laohu8.com/highlight/detail?id=1119940118","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119940118?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 21:41","pubTimestamp":1762436495,"startTime":"0","endTime":"0","summary":"Viatris高管表示印多尔工厂初步修复工作基本完成，并与FDA就进展和重新检查的潜在时间进行了讨论 - 会议电话","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4007","LU2087621335.USD","BK4585","LU1839511570.USD","BK4583","VTRS"],"gpt_icon":0},{"id":"2581093034","title":"品牌药需求强劲，伟哥生产商 Viatris 季度业绩超出预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2581093034","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581093034?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 21:12","pubTimestamp":1762434762,"startTime":"0","endTime":"0","summary":"路透11月6日 - 受中国和新兴市场对其品牌药物的强劲需求推动，制药商 Viatris VTRS.O 周四公布的第三季度利润和收入超出预期。今年 8 月，这家制药商曾表示，在治疗吸烟者肺部疾病的 Yupelri 和治疗哮喘的 Breyna 等新产品的推动下，预计今年中国市场的增长将保持积极态势。目前，Viatris 预计全年每股利润在 2.25 美元至 2.35 美元之间，高于之前预计的每股 2.16 美元至 2.30 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nL4S3WI1FB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU1894683348.USD","SGXZ57979304.SGD","LU0456855351.SGD","BK4007","LU0225284248.USD","LU0122379950.USD","LU1066051498.USD","LU0321505439.SGD","SG9999013999.USD","BK4588","LU1894683264.USD","SG9999003800.SGD","IE00BLSP4452.SGD","LU0225771236.USD","LU0058720904.USD","VTRS","SG9999002232.USD","SG9999011175.SGD","BK4534","BK4592","BK4550","LU0306806265.USD","SG9999002224.SGD","IE000M9KFDE8.USD","BK4585","LU2087621335.USD","LU0868494617.USD","LU1023059063.AUD","LU1839511570.USD","LU0321505868.SGD","SG9999001176.SGD","BK4533","IE00BBT3K403.USD","LU1057294990.SGD","BK4583","LU0289739699.SGD","LU0170899867.USD","IE0002270589.USD","IE00B19Z3581.USD","LU0985481810.HKD","BK4568","IE00B19Z3B42.SGD","IE00BLSP4239.USD","LU0234572021.USD","LU0306807586.USD","LU1883839398.USD","LU1066053197.SGD","BK4599"],"gpt_icon":1},{"id":"2581064775","title":"由于 COVID 疫苗销售疲软，莫德纳 下调了全年预期上限","url":"https://stock-news.laohu8.com/highlight/detail?id=2581064775","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581064775?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 20:00","pubTimestamp":1762430404,"startTime":"0","endTime":"0","summary":"由于 COVID 疫苗销售疲软，莫德纳 下调了全年预期上限莫德纳 第三季度收入同比下降 45新冠 疫苗的销售额为 9.71 亿美元，高于降低的预期首席财务官称疾控中心迟来的指导意见损害了 COVID 疫苗的销售额Patrick Wingrove. 路透11月6日 - 莫德纳 MRNA.O周四将其2025年收入预期的上限下调了2亿美元，理由是由于美国人难以获得新冠疫苗，该疫苗在美国的销售额低于预期。8 月，美国食品和药物管理局限制老年人和高危人群接种更新的 COVID 疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nL4T3WI153:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015978.USD","BK4501","BK4585","LU0289739699.SGD","BK4550","LU1430594728.SGD","LU2087621335.USD","IE00BZ1G4Q59.USD","MRNA","LU0882574055.USD","LU2324357040.USD","LU1674673691.USD","LU0225771236.USD","BK4534","LU1057294990.SGD","SG9999013999.USD","LU0985481810.HKD","LU0122379950.USD","LU1023059063.AUD","LU0889565916.HKD","BK4007","IE00B19Z3581.USD","BK4533","IE00B7SZLL34.SGD","LU0109394709.USD","SG9999001176.USD","SG9999015945.SGD","LU0170899867.USD","BK4583","LU0456855351.SGD","BK4578","LU2089984988.USD","LU0321505439.SGD","LU1674673428.USD","BK4568","LU0114720955.EUR","LU0058720904.USD","LU0234572021.USD","LU0320765992.SGD","GILD","LU1894683348.USD","SG9999015952.SGD","IE00BBT3K403.USD","BK4599","LU1066053197.SGD","IE00B3T34201.USD","IE000M9KFDE8.USD","BK4566","BK4588"],"gpt_icon":1}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":35,"code":"91000000","status":"200"}]}}